Joy Wolfram
Finnish nanoscientist, PhD, assistant professor
Joy Wolfram's AcademicInfluence.com Rankings
Download Badge
Philosophy
Joy Wolfram's Degrees
- PhD Nanoscience University of Helsinki
Why Is Joy Wolfram Influential?
(Suggest an Edit or Addition)According to Wikipedia, Joy Wolfram is a Finnish nanoscientist. She is known for her pioneering work in nanomedicine concerning the treatment of cancer, cardiovascular diseases and other life-threatening illnesses. She is an Associate Professor at the University of Queensland, in the school of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology. She was the forefront of the Extracellular Vesicles and Nanomedicine laboratory at Mayo Clinic. She is also an affiliate faculty member at Houston Methodist Hospital's Department of Nanomedecine. Wolfram sits as a scientific advisor and as a board member of several biotechnology companies around the world.
Joy Wolfram's Published Works
Published Works
- Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines (2018) (5288)
- Safety of Nanoparticles in Medicine. (2015) (321)
- Insights from nanomedicine into chloroquine efficacy against COVID-19 (2020) (248)
- Clinical Cancer Nanomedicine. (2019) (238)
- Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid (2018) (195)
- Extracellular vesicle-based drug delivery systems for cancer treatment (2019) (180)
- The nano-plasma interface: Implications of the protein corona. (2014) (158)
- Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics (2014) (154)
- Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. (2013) (132)
- On the issue of transparency and reproducibility in nanomedicine (2019) (128)
- Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. (2015) (116)
- High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. (2013) (102)
- A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery (2017) (98)
- Multifunctional Gold Nanorods for siRNA Gene Silencing and Photothermal Therapy (2014) (94)
- Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells (2013) (92)
- Extracellular vesicles versus synthetic nanoparticles for drug delivery (2021) (92)
- A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer. (2017) (92)
- Shrinkage of pegylated and non-pegylated liposomes in serum. (2014) (88)
- Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. (2014) (78)
- Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells (2014) (75)
- The solid progress of nanomedicine (2020) (75)
- Extracellular vesicle therapeutics for liver disease (2018) (71)
- Contribution of Kupffer cells to liposome accumulation in the liver. (2017) (70)
- Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors (2013) (66)
- Extracellular Vesicles in Cancer Detection: Hopes and Hypes. (2020) (60)
- Chloroquine and nanoparticle drug delivery: A promising combination (2018) (55)
- Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles (2019) (54)
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation (2019) (53)
- Multistage vector (MSV) therapeutics. (2015) (51)
- Liposomal chemotherapeutics. (2013) (50)
- Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles. (2017) (50)
- Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer. (2016) (50)
- A Micro/Nano Composite for Combination Treatment of Melanoma Lung Metastasis (2016) (44)
- Enzyme-responsive multistage vector for drug delivery to tumor tissue. (2016) (43)
- Strategies for improving drug delivery: nanocarriers and microenvironmental priming (2017) (41)
- Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway. (2012) (41)
- Post-nano strategies for drug delivery: Multistage porous silicon microvectors. (2017) (39)
- Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosis (2015) (39)
- Taking the vehicle out of drug delivery. (2017) (38)
- A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells (2018) (37)
- Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. (2015) (36)
- Porous silicon microparticles for delivery of siRNA therapeutics. (2015) (34)
- Adipose-Derived Biogenic Nanoparticles for Suppression of Inflammation. (2020) (34)
- Hesperetin Liposomes for Cancer Therapy. (2016) (33)
- Lipoprotein-based drug delivery. (2020) (29)
- Brain metastases-derived extracellular vesicles induce binding and aggregation of low-density lipoprotein (2020) (29)
- Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection (2016) (29)
- Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer (2018) (23)
- Extracellular vesicles for treatment of solid organ ischemia–reperfusion injury (2020) (20)
- Extracellular vesicle therapeutics from plasma and adipose tissue. (2021) (18)
- Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. (2014) (17)
- MISEV 2018 ) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV 2014 guidelines (2018) (17)
- Glycan Node Analysis of Plasma-Derived Extracellular Vesicles (2020) (14)
- Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays (2022) (14)
- A Simple and Quick Method for Loading Proteins in Extracellular Vesicles (2021) (13)
- Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2) (2015) (11)
- Advances in Nanotechnology-Based Drug Delivery Platforms and Novel Drug Delivery Systems (2015) (8)
- Systematic comparison of methods for determining the in vivo biodistribution of porous nanostructured injectable inorganic particles. (2019) (7)
- Extracellular vesicle glucose transporter-1 and glycan features in monocyte-endothelial inflammatory interactions. (2022) (7)
- A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells. (2016) (7)
- Live‐cell single‐molecule imaging reveals clathrin and caveolin‐1 dependent docking of SMAD4 at the cell membrane (2013) (6)
- Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines (2021) (5)
- Education and Outreach in Physical Sciences in Oncology. (2020) (4)
- Extracellular vesicles as personalized medicine. (2022) (3)
- Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (2019) (3)
- Sucrose-based cryoprotective storage of extracellular vesicles (2022) (2)
- The cancer cell-derived extracellular vesicle glycocode in immunoevasion. (2022) (2)
- Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (2019) (1)
- Mechanistic Features of Nanodiamonds in the Lapping of Magnetic Heads (2014) (1)
- Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis. (2022) (1)
- The Impact of Lubricants on the Precision Lapping Process (2014) (1)
- Patients as biomedical researchers. (2022) (1)
- RAB27B Drives a Cancer Stem Cell Phenotype in NSCLC Cells Through Enhanced Extracellular Vesicle Secretion. (2023) (0)
- Abstract LB-019: Empowering preclinical studies: A systematic and quantitative analysis of biodistribution methods to facilitate clinical translation of new drugs (2018) (0)
- Nanomedicine Activities in the United States and Worldwide (2016) (0)
- Unraveling multilayered extracellular vesicles: Speculation on cause (2023) (0)
- The solid progress of nanomedicine (2020) (0)
- Systematic Comparison of Methods for Determining the in vivo Biodistribution of Porous Nanostructured Injectable Inorganic Particles (2019) (0)
- Abstract B04: From modeling to in vivo tracking: a new platform for the design of delivery vectors that exploit tumor microfluidics (2017) (0)
- Regenerative medicine therapy: adipose derived extracellular vesicles in viral myocarditis (2020) (0)
- Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles (2019) (0)
- A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery (2017) (0)
- Abstract 2444: RAB27B drives a cancer stem cell phenotype in non-small cell lung cancer cells through enhanced extracellular vesicle secretion (2023) (0)
- Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells (2023) (0)
- Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2) (2015) (0)
- Systemic delivery of human bone-marrow derived extracellular vesicles ameliorates kidney injury and inflammation in an accelerated diabetic kidney disease mouse model (2021) (0)
This paper list is powered by the following services:
Other Resources About Joy Wolfram
What Schools Are Affiliated With Joy Wolfram?
Joy Wolfram is affiliated with the following schools: